Early administration of tecovirimat shortens the time to mpox clearance in a model of human infection.

Despite use of tecovirimat since the beginning of the 2022 outbreak, few data have been published on its antiviral effect in humans. We here predict tecovirimat efficacy using a unique set of data in nonhuman primates (NHPs) and humans. We analyzed tecovirimat antiviral activity on viral kinetics in...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Bach Tran Nguyen, Aurélien Marc, Clara Suñer, Michael Marks, Maria Ubals, Águeda Hernández-Rodríguez, María Ángeles Melendez, Movie Group, Dennis E Hruby, Andrew T Russo, France Mentré, Oriol Mitjà, Douglas W Grosenbach, Jérémie Guedj
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Public Library of Science (PLoS) 2023-12-01
סדרה:	PLoS Biology
גישה מקוונת:	https://doi.org/10.1371/journal.pbio.3002249
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!